Latest News about MRK
Recent news which mentions MRK
Merck/Eisai's Keytruda Plus Lenvima Regime Shows Mixed Data In Esophagus Cancer Study
January 24, 2025
From Benzinga
From Benzinga
From Motley Fool
From Benzinga
Why Summit Therapeutics Stock Is Jumping Today
January 21, 2025
From Motley Fool
From Motley Fool
Popular Ozempic, Wegovy Selected For Next Round Of Medicare Drug Price Negotiations
January 17, 2025
From Benzinga
3 Magnificent S&P 500 Dividend Stocks Down 25%, 60%, and 26% to Buy and Hold Forever
January 16, 2025
From Motley Fool
Price Over Earnings Overview: Merck & Co
January 15, 2025
From Benzinga
Obesity Treatments, M&A Activity To Take Center Stage During Upcoming JPM Healthcare Conference
January 09, 2025
From Benzinga
From Benzinga
From Benzinga
Bullish Outlook On Instil Bio's Investigational Cancer Drug: Jefferies Sees Over 300% Stock Upside
January 07, 2025
From Benzinga
Unpacking the Latest Options Trading Trends in Merck & Co
January 07, 2025
Tickers
MRK
From Benzinga
From Benzinga
Viking Therapeutics, Structure Therapeutics Positioned As Key Pharma Partners For Weight Loss Products: Analyst
January 06, 2025
From Benzinga
Why Viking Therapeutics Stock Plummeted by 24% in December
January 04, 2025
From Motley Fool
Should You Buy the Dip on This High-Flying Stock?
January 03, 2025
From Motley Fool
UK Approves Merck's Hypertension Drug Acquired Via $11 Billion Acceleron Pharma Deal
January 02, 2025
From Benzinga
From Benzinga
2 High-Yield Dividend Stocks to Buy Early in 2025
December 31, 2024
From Motley Fool
Will This Major Pharmaceutical Stock Announce a Stock Split in 2025?
December 30, 2024
From Motley Fool
3 Stocks That Could Be Monster Winners in 2025
December 29, 2024
From Motley Fool
Top 7 Blue-Chip Stocks With The Best Return Potential Going Into 2025
December 25, 2024
From Benzinga
Big Biopharma Trails Behind The Market: JP Morgan's 2025 Outlook on Eli Lilly, Merck, and More
December 22, 2024
From Benzinga
Is Merck the Next Big Weight-Loss Stock?
December 22, 2024
From Motley Fool
Down 18% in 1 Day, Is Viking Therapeutics Stock in Trouble Due to Merck?
December 21, 2024
From Motley Fool
Why Viking Therapeutics Tumbled by More Than 10% This Week
December 20, 2024
From Motley Fool
Want to Collect a Dividend Every Month? Invest in These 3 High-Yielding Income Stocks
December 20, 2024
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
More ways to get to us
Facebook
Twitter
YouTubeContact the Lethbridge Herald
504 - 7th Street South
Lethbridge, AB T1J 3Z7
[P] (403) 328-4411
[F] (403)328-4536
Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433
© 1996-2017 The Lethbridge Herald, A Division of Continental Newspapers Canada Ltd.